You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The startup wants to serve the 50 percent or so of genetic disease patients who haven't obtained a molecular diagnosis despite extensive testing.
The company plans to offer four new products by the end of the year, including four targeted transcriptomic panels and IHC compatibility for Visium.
ArcherDx has signed separate agreements to integrate its target enrichment assays with PierianDx's software and with MPLN's oncology testing services.
The facility was named a certified service provider for Agilent's next-generation sequencing technologies.
CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.
PacBio's CSP program is a global network of service providers that have been validated to provide sequencing services on the RS II system.
The CSP program is a global network of service providers that have been validated to provide sequencing services on the RS II system.
The firm was named a certified service provider for Agilent's SureSelect Methyl-Seq target enrichment.
In order to get Illumina CSP status, the company underwent a two-step process to ensure that it follows Illumina's best practices.
Alacris' ModCell approach matches patients with appropriate therapies.
The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.
The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.
Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.
In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.